Berinert (C1 esterase inhibitor, human) — United Healthcare
hereditary angioedema (HAE)
Initial criteria
- Diagnosis of hereditary angioedema (HAE)
- Used for the treatment of acute HAE attacks
- Not used in combination with other products indicated for acute HAE attacks (e.g., Firazyr, Kalbitor or Ruconest)
Approval duration
12 months